FDA approves first intratumoral injection to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg.
Read more: FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs